Inventor · disambiguated record
Joakim Tedroff
Also filed as: ROENNQVIST LEGAL REPRESENTATIV · ROENNQVIST LISELOTT LILJA · TEDROFF JOAKIM · TEDROFF JOAKIM MIHKEL
6 granted patents·3 pending applications·139 citations·filing 2000–2025
84Inventor score
Files withCARLSSON A RESEARCH AB2INTEGRATIVE RES LABORATORIES SWEDEN AB2NEUROSEARCH SWEDEN AB2HOLM WATERS SUSANNA1TEVA PHARMACEUTICALS INT GMBH1
Top patents by PatentIndex Score
9 records- 0191US6903120B2Modulators of dopamine neurotransmissionCARLSSON A RESEARCH AB·Filed 2000·Granted Jun 7, 2005·56 cites·37 claims
- 0289USRE46117EModulators of dopamine neurotransmissionTEVA PHARMACEUTICALS INT GMBH·Filed 2000·Granted Aug 23, 2016·28 cites·52 claims
- 0385US7417043B2Modulators of dopamine neurotransmissionNEUROSEARCH SWEDEN AB·Filed 2004·Granted Aug 26, 2008·28 cites·8 claims
- 0483US6924374B2Modulators of dopamine neurotransmissionCARLSSON A RESEARCH AB·Filed 2000·Granted Aug 2, 2005·24 cites·7 claims
- 0569US2024148674A1Pharmaceutically acceptable salts of mesdopetam and uses thereofWATERS SUSANNA HOLM·Filed 2023·Application pending·0 cites
- 0668US2025243155A1Pharmaceutically Acceptable Salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and Uses ThereofINTEGRATIVE RES LABORATORIES SWEDEN AB·Filed 2025·Application pending·0 cites
- 0766US12275694B2Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereofINTEGRATIVE RES LABORATORIES SWEDEN AB·Filed 2020·Granted Apr 15, 2025·0 cites·17 claims
- 0865USRE41315EModulators of dopamine neurotransmissionNEUROSEARCH SWEDEN AB·Filed 2000·Granted May 4, 2010·3 cites·17 claims
- 0960US2022168242A1Pharmaceutically acceptable salts of mesdopetam and uses thereofHOLM WATERS SUSANNA·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →